Author

Johannes B. Prins

University of Queensland, Mater Medical Research Institute, Cambridge - Cited by 19,306 - Medicine - Endocrinology - Diabetes - Obesity

Biography

Johannes B. Prins is a  Scientist.  Johannes B. Prins works as a CEO, Mater Medical Research Institute, Brisbane, Australia. his area of research intrest include:-History; Insulin; Recombinant; Methods of delivery Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia
Title
Cited by
Year
The prevalence and impact of overweight and obesity in an Australian obstetric population
LK Callaway, AM Chang, HD McIntyre, JB PrinsMedical journal of Australia 184 (2), 56-59, 2006200
859
2006
Adiponectin–a key adipokine in the metabolic syndrome
JP Whitehead, AA Richards, IJ Hickman, GA Macdonald, JB PrinsDiabetes, Obesity and Metabolism 8 (3), 264-280, 2006200
844
2006
Fat as an endocrine organ: relationship to the metabolic syndrome
L Hutley, JB PrinsThe American journal of the medical sciences 330 (6), 280-289, 2005200
438
2005
Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia
MD Hordern, DW Dunstan, JB Prins, MK Baker, MAF Singh, JS CoombesJournal of Science and Medicine in Sport 15 (1), 25-31, 2012201
409
2012
Inflammatory lipid mediators in adipocyte function and obesity
A Iyer, DP Fairlie, JB Prins, BD Hammock, L BrownNature Reviews Endocrinology 6 (2), 71-82, 2010201
348
2010
The link between abdominal obesity and the metabolic syndrome
LK Phillips, JB PrinsCurrent hypertension reports 10 (2), 156-164, 2008200
244
2008
Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational …
AA Richards, T Stephens, HK Charlton, A Jones, GA Macdonald, JB Prins, ...Molecular endocrinology 20 (7), 1673-1687, 2006200
237
2006
Resveratrol–pills to replace a healthy diet?
VS Chachay, CMJ Kirkpatrick, IJ Hickman, M Ferguson, JB Prins, ...British journal of clinical pharmacology 72 (1), 27-38, 2011201
162
2011
Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification
DW Johnson, K Armstrong, SB Campbell, DW Mudge, CM Hawley, ...Nephrology 12 (4), 391-398, 2007200
157
2007
Update on incretin hormones
LK Phillips, JB PrinsAnnals of the New York Academy of Sciences 1243 (1), E55-E74, 2011201
154
2011
Effects of exercise intervention on myocardial function in type 2 diabetes
MD Hordern, JS Coombes, LM Cooney, L Jeffriess, JB Prins, TH MarwickHeart 95 (16), 1343-1349, 2009200
117
2009
Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes
CH Widberg, FS Newell, AW Bachmann, SN Ramnoruth, MC Spelta, ...American Journal of Physiology-Endocrinology and Metabolism 296 (1), E121-E131, 2009200
107
2009
Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population
J Cohen, G Ward, J Prins, M Jones, B VenkateshIntensive care medicine 32, 1901-1905, 2006200
95
2006
Abnormal NF-κB function characterizes human type 1 diabetes dendritic cells and monocytes
ZUA Mollah, S Pai, C Moore, BJ O’Sullivan, MJ Harrison, J Peng, ...The Journal of Immunology 180 (5), 3166-3175, 2008200
91
2008
Incretin‐based therapies–review of the physiology, pharmacology and emerging clinical experience
JH Martin, CF Deacon, MD Gorrell, JB PrinsInternal medicine journal 41 (4), 299-307, 2011201
88
2011
Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with …
AA Richards, IJ Hickman, AYH Wang, AL Jones, F Newell, BJ Mowry, ...Journal of Clinical Psychopharmacology 26 (3), 232-237, 2006200
87
2006
Characterization of the transcriptional and functional effects of fibroblast growth factor‐1 on human preadipocyte differentiation
FS Newell, H Su, H Tornqvist, JP Whitehead, JB Prins, LJ Hutley, ...The FASEB journal 20 (14), 2615-2617, 2006200
84
2006
Determinants of changes in blood glucose response to short-term exercise training in patients with Type 2 diabetes
MD Hordern, LM Cooney, EM Beller, JB Prins, TH Marwick, JS CoombesClinical Science 115 (9), 273-281, 2008200
84
2008
Patients with type 2 diabetes have exaggerated brachial and central exercise blood pressure: relation to left ventricular relative wall thickness
JA Scott, JS Coombes, JB Prins, RL Leano, TH Marwick, JE SharmanAmerican journal of hypertension 21 (6), 715-721, 2008200
82
2008
TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue—influence of BMI and adipose distribution
M Good, FM Newell, LM Haupt, JP Whitehead, LJ Hutley, JB PrinsDiabetes and Vascular Disease Research 3 (1), 26-33, 2006200
80
2006

Referred From: https://scholar.google.com.au/citations?user=4aJ_sBAAAAAJ&hl=en

Cited by
Citations 19306
h-index 60
i10-index 91
Recommended Journals
Open Access Journals